Differentiation of y79 retinoblastoma cells with pigment epithelial-derived factor and interphotoreceptor matrix wash: Effects on tumorigenicity

  • Gail M. Seigel
  • , Joyce Tombran-Tink
  • , S. Patricia Becerra
  • , Gerald J. Chader
  • , David A. Diloreto
  • , Constancia Del Cerro
  • , Eliot S. Lazar
  • , Manuel Del Cerro

    Research output: Contribution to journalArticlepeer-review

    35 Scopus citations

    Abstract

    We investigated the in vivo differentiation potential of Y79 human retinoblastoma cells following pre-treatment with two novel neurotrophic agents: PEDF (human recombinant pigmented-epithelial derived factor) or IPM (interphotoreceptor matrix) wash. These agents were able to induce a significant degree of morphological differentiation in vitro. However, 48 days after subretinal transplantation of pre-treated cells, massive tumor formation was apparent. In contrast, Y79 cells pre-treated with retinoic acid/sodium butyrate, which attain a lesser degree of morphological differentiation, did not produce tumors over a 30 to 60 day-survival time (del Cerro et al., Brain Research, 12-22, 1992). We conclude that for PEDF and IPM, the degree of in vitro differentiation and the degree of mitotic arrest are independent features.

    Original languageEnglish (US)
    Pages (from-to)289-297
    Number of pages9
    JournalGrowth Factors
    Volume10
    Issue number4
    DOIs
    StatePublished - 1994

    All Science Journal Classification (ASJC) codes

    • Endocrinology
    • Clinical Biochemistry
    • Cell Biology

    Fingerprint

    Dive into the research topics of 'Differentiation of y79 retinoblastoma cells with pigment epithelial-derived factor and interphotoreceptor matrix wash: Effects on tumorigenicity'. Together they form a unique fingerprint.

    Cite this